Hereditary Angioedema - Market Insights, Epidemiology and Market Forecast - 2025

LONDON, Nov. 9, 2017 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5144653

The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Hereditary Angioedema from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Hereditary Angioedema till 2025.The Report also covers market drivers, market barriers and unmet medical need.

This report provides the subtype specific prevalent population i.e. Type I (HAE-I), Type II (HAE-II) and Type III (HAE with Normal C1-INH). According to DelveInsight, the prevalent population of Hereditary Angioedema is expected to reach up to XXX cases by the end of 2025 at a CAGR of 0.59% from 2015-2025. High prevalent cases were observed in United States as compared to EU5 and Japan.

Increase in the drugs under pipeline for HAE screening tests is one of the major drivers for the Hereditary Angioedema therapeutics market globally. There is continuous market increase for HAE due to Shire's product, which is currently dominating in HAE market with the leading treatment for both the long-term prophylaxis (Cinryze), and the Acute Setting (Firazyr).

United States contributes the major share of Hereditary Angioedema market as compared to EU5 countries and Japan. The therapeutic market of Hereditary Angioedema in 7MM is expected to reach USD 2.8 Billion in 2025 at the CAGR of XX% from 2015-2025.

Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Hereditary Angioedema market.
• Organize sales and marketing efforts by identifying the best opportunities for Hereditary Angioedema in US, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
• To understand the future market competition in the Hereditary Angioedema market and Insightful review of the key market drivers and barriers.
• To understand the regulatory scenario in major markets.
• The report provides historical as well as forecasted epidemiology of Hereditary Angioedema in the 7MM covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.
• The Report also covers the detailed historical and forecasted Hereditary Angioedema market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.

Download the full report: https://www.reportbuyer.com/product/5144653

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com